Page last updated: 2024-11-05
triazolam and Snoring
triazolam has been researched along with Snoring in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Snoring: Rough, noisy breathing during sleep, due to vibration of the uvula and soft palate.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Schneider, H | 1 |
Grote, L | 1 |
Peter, JH | 1 |
Cassel, W | 1 |
Guilleminault, C | 1 |
Trials
1 trial available for triazolam and Snoring
Article | Year |
---|---|
The effect of triazolam and flunitrazepam--two benzodiazepines with different half-lives--on breathing during sleep.
Topics: Adult; Anti-Anxiety Agents; Cross-Over Studies; Double-Blind Method; Esophagus; Flunitrazepam; Half- | 1996 |